OBJECTIVE: To illustrate the role of long non-coding RNA (lncRNA) TUG1 in the influence of
the progression of cervical cancer (CC) and its underlying mechanism. PATIENTS AND …

Background Non-small cell lung cancer (NSCLC) is one of the most common malignancies
with the highest morbidity and mortality worldwide. Long non-coding RNAs (lncRNAs) are …

Background Pre-eclampsia (PE) is regarded as the leading cause of maternal and neonatal
morbidity and mortality. Nevertheless, the potential mechanism for the regulation of …

Background Hepatocellular carcinoma (HCC) is characterised by high malignancy,
metastasis and recurrence, but the specific mechanism that drives these outcomes is …

Background. Chemoresistance and tumor recurrence lead to high deaths in colorectal
cancer (CRC) patients. Cancer stem cells (CSCs) contribute to these pathologic properties …

Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor worldwide.
Long noncoding RNAs (lncRNAs) exhibit a regulatory role in the progression of ESCC. Our …

Recently, it is reported that taurine upregulated gene 1 (TUG1) participates in the tumor
progression by acting as a competing endogenous RNA (ceRNA) of miRNAs. Nonetheless …

Recently, a novel class of transcripts, long non-coding RNAs (lncRNAs), is being identified
at a rapid pace. These RNAs have critical roles in diverse biological processes, including …

LncRNA TUG1 has been demonstrated to be aberrantly expressed in several types of
cancer and maybe serve as a prognostic marker for cancer patients. However, most …

The aim of the present study was to investigate the function of long non‑coding RNA taurine‑
upregulated gene 1 (lncRNA TUG1) in chronic obstructive pulmonary disease and further …